|
시장보고서
상품코드
2056354
동물 모델 시장 보고서 : 동물 유형, 기술, 용도, 최종사용자, 지역별(2026-2034년)Animal Model Market Report by Animal Type, Technology, Application, End User, and Region 2026-2034 |
||||||
세계의 동물 모델 시장 규모는 2025년에 20억 2,490만 달러에 달했습니다. 향후에 대해 IMARC Group은 2026-2034년에 CAGR 5.46%로 추이하며, 2034년까지 33억 1,360만 달러에 달할 것으로 예측하고 있습니다.
동물 모델이란 의학 연구나 조사에 사용되는 인간 이외의 생물을 말합니다. 이들은 인간의 유전학, 해부학, 생리와 매우 유사하므로 자주 선택됩니다. 이들은 인간에게 해를 끼치지 않고 질병의 예방, 진단, 치료에 대한 정보를 얻을 수 있도록 도와줍니다. 일반적으로 사용되는 동물 모델로는 설치류, 쥐, 쥐, 생쥐, 고슴도치, 기니피그, 기니피그, 햄스터 등이 있습니다. 현재 이 동물들은 쉽게 구할 수 있고, 다루기 쉬우며, 상대적으로 낮은 사용 비용으로 인해 널리 선호되고 있습니다.
동물 모델 시장 동향:
현재 전 세계에서 맞춤형 의료에 대한 요구가 지속적으로 증가하고 있습니다. 여기에 다운증후군, 크론병, 유방암, 혈우병과 같은 유전성 질환의 유병률 증가가 더해져 연구자들이 의약품 비임상 개발에서 동물모델을 사용하는 주요 요인 중 하나가 되고 있습니다. 이 외에도 동물 모델은 전 세계에서 생의학 연구, 독성학, 생리학, 생리학, 암 연구, 신경학 연구, 유전학 연구, 이종 이식 등 다양한 분야에서 활용되고 있습니다. 또한 유전체 편집 기술인 CRISPR-Cas9의 도입 등 수많은 기술적 진보가 시장을 주도하고 있으며, 이를 통해 광범위한 유전자 변형 동물 모델 제작에 필요한 시간과 비용을 절감할 수 있게 되었습니다. 이 기술은 초기 분지 다세포 생물에서 영장류에 이르기까지 다양한 동물에 광범위하게 적용되고 있습니다. 여기에 전염성이 강한 신종 코로나바이러스 감염증(COVID-19)의 갑작스러운 유행도 시장에 긍정적인 전망을 낳고 있습니다. 이는 백신 및 항바이러스제 도입을 위한 연구개발(R&D) 활동에 대한 세계보건기구(WHO)와 정부 당국 등 국제기구의 투자가 증가하고 있기 때문으로 풀이됩니다.
이 보고서에서 답변하는 주요 질문:
- 지금까지의 세계 동물모델 시장의 동향은 어떠했으며, 향후 수년간 어떻게 변화하는가?
- COVID-19가 글로벌 동물 모델 시장에 어떤 영향을 미쳤는가?
- 주요 지역 시장은 어디인가?
- 동물 유형별 시장 현황은?
- 기술별 시장 현황은?
- 용도별 시장 현황은?
- 최종사용자별 시장 분석은 어떻게 이루어지고 있는가?
- 이 산업의 밸류체인에서 각 단계는 무엇인가?
- 이 산업의 주요 촉진요인과 과제는 무엇인가?
- 세계의 동물 모델 시장의 구조는 무엇이며, 주요 기업은 어디인가?
- 업계내 경쟁은 어느 정도 치열한가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 동물 모델 시장
제6장 시장 내역 : 동물 유형별
제7장 시장 내역 : 기술별
제8장 시장 내역 : 용도별
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
KSA 26.06.16The global animal model market size reached USD 2,024.9 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 3,313.6 Million by 2034, exhibiting a growth rate (CAGR) of 5.46% during 2026-2034.
Animal models are living, non-human species used in medical research and investigations. They are frequently selected due to their vast similarities with the genetics, anatomy, and physiology of humans. They assist in obtaining information about the prevention, diagnosis, and treatment of diseases without causing harm to a human. Some of the commonly utilized animal models include rodents, rats, mice, gerbils, guinea pigs, and hamsters. At present, they are widely preferred on account of their availability, ease of handling, and relatively low cost of use.
Animal Model Market Trends:
Presently, there is a continuous increase in the need for personalized medicines across the globe. This, in confluence with a rising prevalence of genetic disorders, such as down syndrome, Crohn's disease, breast cancer, and hemophilia, represents one of the key factors positively influencing the utilization of animal models in the pre-clinical development of drugs by researchers. Apart from this, they are also being utilized in biomedical research, toxicology, physiology, cancer research, neurological research, genetic research, and xenotransplantation around the world. Furthermore, the market is propelled by numerous technological advancements, such as the introduction of CRISPR-Cas9, a genome editing technology, which aids in reducing the time and cost required for enabling the production of animal models with extensive genetic modifications. This technology finds wide applicability in a variety of animals, ranging from early-branching metazoans to primates. Besides this, the sudden outbreak of the contagious coronavirus disease (COVID-19) pandemic is creating a favorable outlook for the market. This can be accredited to the increasing investments by international organizations like World Health Organization (WHO) and government authorities in research and development (R&D) activities to introduce vaccines and antiviral drugs.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global animal model market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on animal type, technology, application, and end user.
Breakup by Animal Type:
- Rat
- Mice
- Guinea Pigs
- Rabbits
- Others
Breakup by Technology:
- CRISPR
- Embryonic Stem Cell Injection
- Nuclear Transfer
- Others
Breakup by Application:
- Drug Discovery and Development
- Basic Research
- Others
Breakup by End User:
- Pharma and Biotech Companies
- Academic Research Institutes
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biocytogen, Charles River Laboratories International Inc, Envigo, Eurofins Scientific SE, GenOway S.A., Hera BioLabs, JSR Corporation, Ozgene Pty Ltd., PerkinElmer Inc., Taconic Biosciences Inc., The Jackson Laboratory and Trans Genic Inc.
Key Questions Answered in This Report:
- How has the global animal model market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global animal model market?
- What are the key regional markets?
- What is the breakup of the market based on the animal type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global animal model market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Animal Model Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Animal Type
- 6.1 Rat
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Mice
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Guinea Pigs
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Rabbits
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Technology
- 7.1 CRISPR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Embryonic Stem Cell Injection
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Nuclear Transfer
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Application
- 8.1 Drug Discovery and Development
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Basic Research
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Pharma and Biotech Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Academic Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Biocytogen
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 Charles River Laboratories International Inc
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Envigo
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Eurofins Scientific SE
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 GenOway S.A.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.6 Hera BioLabs
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 JSR Corporation
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Ozgene Pty Ltd.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 PerkinElmer Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Taconic Biosciences Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 The Jackson Laboratory
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.12 Trans Genic Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 Biocytogen
